Shopping Cart
Remove All
Your shopping cart is currently empty
PF-5212374
(Synonyms: TRU-015) Copy Product Info
🥰Excellent
Synonyms: TRU-015
Catalog No. T9901A-1262 Copy Product Info
🥰Excellent
PF-5212374 (TRU-015) is a CD20-directed small modular immunopharmaceutical (SMIP). Unlike traditional full-length antibodies, TRU-015 is a dimeric fusion protein comprising a single-chain Fv (scFv) binding domain coupled to the hinge and Fc regions of IgG1. It specifically binds to CD20 on the surface of B cells, activating Immunology/Inflammation-related signaling pathways to effectively mediate antibody-dependent cellular cytotoxicity (ADCC) and direct induction of apoptosis, resulting in the depletion of both normal and malignant B cells.
Cas No. 1169717-01-4
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $222 | Inquiry | Inquiry | |
| 5 mg | $668 | Inquiry | Inquiry | |
| 10 mg | $1,070 | Inquiry | Inquiry |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | PF-5212374 (TRU-015) is a CD20-directed small modular immunopharmaceutical (SMIP). Unlike traditional full-length antibodies, TRU-015 is a dimeric fusion protein comprising a single-chain Fv (scFv) binding domain coupled to the hinge and Fc regions of IgG1. It specifically binds to CD20 on the surface of B cells, activating Immunology/Inflammation-related signaling pathways to effectively mediate antibody-dependent cellular cytotoxicity (ADCC) and direct induction of apoptosis, resulting in the depletion of both normal and malignant B cells. |
| In vitro | PF-5212374 (TRU-015) specifically binds human CD20. In Ramos or Daudi cells, it exhibits potent ADCC activity in the presence of NK cells. At nanomolar concentrations, it efficiently induces direct cell death and clears B cells in PBMC cultures [1]。 |
| In vivo | In pharmacological studies using non-human primate models (cynomolgus monkeys), systemic administration of PF-5212374 (at doses ranging from 0.1 to 10 mg/kg) results in rapid and sustained depletion of peripheral B cells. The treatment demonstrates effective lymphoid tissue penetration, leading to significant B-cell reduction in lymph nodes and spleen within complex physiological environments [1]. |
| Synonyms | TRU-015 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | CD20/MS4A1 |
| Cas No. | 1169717-01-4 |
| Isotype | IgG1 |
| Storage | Store at low temperature Store at -20°C Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: PF-5212374 chemical structure | PF-5212374 in vivo | PF-5212374 in vitro
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.